Terms: = Germ cell tumor AND FOXP3, AIID, DIETER, IPEX, JM2, PIDX, XPID
406 results:
1. foxp3 promote the progression of glioblastoma via inhibiting ferroptosis mediated by linc00857/miR-1290/GPX4 axis.
Cao W; He Y; Lan J; Luo S; Sun B; Xiao C; Yu W; Zeng Z; Lei S
Cell Death Dis; 2024 Apr; 15(4):239. PubMed ID: 38561331
[TBL] [Abstract] [Full Text] [Related]
2. Comparing anti-tumor and anti-self immunity in a patient with melanoma receiving immune checkpoint blockade.
Chen S; McMiller TL; Soni A; Succaria F; Sidhom JW; Cappelli LC; Casciola-Rosen LA; Morales IR; Sankaran P; Berger AE; Deutsch JS; Zhu QC; Anders RA; Hooper JE; Pardoll DM; Lipson EJ; Taube JM; Topalian SL
J Transl Med; 2024 Mar; 22(1):241. PubMed ID: 38443917
[TBL] [Abstract] [Full Text] [Related]
3. Immune infiltration, aggressive pathology, and poor survival outcomes in RECQL helicase deficient breast cancers.
Lashen A; Al-Kawaz A; Jeyapalan JN; Alqahtani S; Shoqafi A; Algethami M; Toss M; Green AR; Mongan NP; Sharma S; Akbari MR; Rakha EA; Madhusudan S
Neoplasia; 2024 Jan; 47():100957. PubMed ID: 38134458
[TBL] [Abstract] [Full Text] [Related]
4. Cancer-associated fibroblasts-induced remodeling of tumor immune microenvironment via Jagged1 in glioma.
Zhang Q; Wang J; Zhang J; Wang Y; Wang Y; Liu F
Cell Signal; 2024 Mar; 115():111016. PubMed ID: 38128708
[TBL] [Abstract] [Full Text] [Related]
5. Differential requirements for CD4+ T cells in the efficacy of the anti-PD-1+LAG-3 and anti-PD-1+CTLA-4 combinations in melanoma flank and brain metastasis models.
Phadke MS; Li J; Chen Z; Rodriguez PC; Mandula JK; Karapetyan L; Forsyth PA; Chen YA; Smalley KSM
J Immunother Cancer; 2023 Dec; 11(12):. PubMed ID: 38056899
[TBL] [Abstract] [Full Text] [Related]
6. Celastrol, which targets IL-2/CD25 binding inhibition, induces T cell-mediated antitumor activity in melanoma.
Cho O; Lee JW; Jeong YJ; Kim LK; Jung BK; Heo TH
Eur J Pharmacol; 2024 Jan; 962():176239. PubMed ID: 38043776
[TBL] [Abstract] [Full Text] [Related]
7. LAG3 and TIGIT Expression on tumor-Infiltrating Lymphocytes in Cutaneous Melanoma.
Naimy S; Bzorek M; Eriksen JO; Løvendorf MB; Litman T; Dyring-Andersen B; Gjerdrum LMR
Dermatology; 2024; 240(1):156-163. PubMed ID: 37952520
[TBL] [Abstract] [Full Text] [Related]
8. A Metabolic Gene Survey Pinpoints Fucosylation as a Key Pathway Underlying the Suppressive Function of Regulatory T cells in Cancer.
Pinioti S; Sharma H; Flerin NC; Yu Q; Tzoumpa A; Trusso Cafarello S; De Bousser E; Callewaert N; Oldenhove G; Schlenner S; Thienpont B; Garg AD; Di Matteo M; Mazzone M
Cancer Immunol Res; 2023 Dec; 11(12):1611-1629. PubMed ID: 37933083
[TBL] [Abstract] [Full Text] [Related]
9. Early Immune Changes Support Signet Ring cell Dormancy in CDH1-Driven Hereditary Diffuse Gastric Carcinogenesis.
Green BL; Gamble LA; Diggs LP; Nousome D; Patterson JC; Joughin BA; Gasmi B; Lux SC; Samaranayake SG; Miettinen M; Quezado M; Hernandez JM; Yaffe MB; Davis JL
Mol Cancer Res; 2023 Dec; 21(12):1356-1365. PubMed ID: 37707375
[TBL] [Abstract] [Full Text] [Related]
10. HEV-associated dendritic cells are observed in metastatic tumor-draining lymph nodes of cutaneous melanoma patients with longer distant metastasis-free survival after adjuvant immunotherapy.
Bravo AI; Aris M; Panouillot M; Porto M; Dieu-Nosjean MC; Teillaud JL; Barrio MM; Mordoh J
Front Immunol; 2023; 14():1231734. PubMed ID: 37691949
[TBL] [Abstract] [Full Text] [Related]
11. Clinical significance of the expression of foxp3 and TIGIT in Merkel cell carcinoma.
Iwasaki T; Hayashi K; Matsushita M; Nonaka D; Matsumoto T; Taniguchi M; Kuwamoto S; Umekita Y; Oda Y
Sci Rep; 2023 Aug; 13(1):13114. PubMed ID: 37573372
[TBL] [Abstract] [Full Text] [Related]
12. Mapping high-grade glioma immune infiltration to 5-ALA fluorescence levels: TCGA data computation, classical histology, and digital image analysis.
Lang A; Jeron RL; Lontzek B; Kiesel B; Mischkulnig M; Berghoff AS; Ricken G; Wöhrer A; Rössler K; Lötsch-Gojo D; Roetzer-Pejrimovsky T; Berger W; Hainfellner JA; Höftberger R; Widhalm G; Erhart F
J Neurooncol; 2023 Aug; 164(1):211-220. PubMed ID: 37543970
[TBL] [Abstract] [Full Text] [Related]
13. Immunohistochemical characterisation of the immune landscape in primary uveal melanoma and liver metastases.
Mariani P; Torossian N; van Laere S; Vermeulen P; de Koning L; Roman-Roman S; Lantz O; Rodrigues M; Stern MH; Gardrat S; Lesage L; Champenois G; Nicolas A; Matet A; Cassoux N; Servois V; Romano E; Piperno-Neumann S; Lugassy C; Barnhill R
Br J Cancer; 2023 Sep; 129(5):772-781. PubMed ID: 37443346
[TBL] [Abstract] [Full Text] [Related]
14.
Vaddi PK; Osborne DG; Nicklawsky A; Williams NK; Menon DR; Smith D; Mayer J; Reid A; Domenico J; Nguyen GH; Robinson WA; Ziman M; Gao D; Zhai Z; Fujita M
Front Immunol; 2023; 14():1173035. PubMed ID: 37197667
[TBL] [Abstract] [Full Text] [Related]
15.
Suzuki T; Takei J; Fukasawa N; Suzuki K; Ogawa D; Yamamoto Y; Akasaki Y; Murayama Y; Shimoda M; Miyake K; Tanaka T
World Neurosurg; 2023 Jul; 175():e1364-e1374. PubMed ID: 37187346
[TBL] [Abstract] [Full Text] [Related]
16. Increased circulating monocyte MDSCs positively correlate with serum Interleukin-10 in metastatic melanoma patients.
Mirjačić Martinović K; Vuletić A; Tišma Miletić N; Nedeljković M; Babović N; Matković S; Jurišić V
Innate Immun; 2023 Apr; 29(3-4):37-44. PubMed ID: 37160888
[TBL] [Abstract] [Full Text] [Related]
17. Expression of the immune targets in tumor-infiltrating immunocytes of gestational trophoblastic neoplasia.
Cheng H; Zong L; Yu S; Chen J; Wan X; Xiang Y; Yang J
Pathol Oncol Res; 2023; 29():1610918. PubMed ID: 36875956
[No Abstract] [Full Text] [Related]
18. TNFR2 expression predicts the responses to immune checkpoint inhibitor treatments.
Liao P; Jiang M; Islam MS; Wang Y; Chen X
Front Immunol; 2023; 14():1097090. PubMed ID: 36865537
[TBL] [Abstract] [Full Text] [Related]
19. A UVR-sensor wearable device intervention to reduce sun exposure in melanoma survivors: Results from a randomized controlled trial.
Vogel RI; Luo X; Brown K; Jewett P; Dona AC; Nagler RH; Ahmed RL; Martinson BC; Lazovich D
PLoS One; 2023; 18(2):e0281480. PubMed ID: 36763627
[TBL] [Abstract] [Full Text] [Related]
20. The signaling function of IDO1 incites the malignant progression of mouse B16 melanoma.
Orecchini E; Belladonna ML; Pallotta MT; Volpi C; Zizi L; Panfili E; Gargaro M; Fallarino F; Rossini S; Suvieri C; Macchiarulo A; Bicciato S; Mondanelli G; Orabona C
Oncoimmunology; 2023; 12(1):2170095. PubMed ID: 36733497
[TBL] [Abstract] [Full Text] [Related]
[Next]